SPOTLIGHT

STAY CONNECTED

Twitter LinkedIn 

 

STARTUP NEWS

WUXI NEWS

A Futuristic Biopharma Company Addressing Some of the World’s Biggest Health Problem

By Rich Soll, Senior Advisor, Strategic Initiatives at WuXi AppTec (@richsollwx) For the past few years, PureTech Health has been building a new R&D model for advancing breakthrough scientific discoveries to help solve some of...

WuXi AppTec Announces Listing of Initial Public Offering of Common Stock on Shanghai Stock...

We are pleased to announce WuXi AppTec's  listing of Initial Public Offering of common stock on the Shanghai Stock Exchange. Proceeds from the IPO will be used to build and expand...

WuXi STA Changzhou Site Passes First U.S. FDA Inspection

We are pleased to announce STA Pharmaceutical Co., Ltd., (WuXi STA), a subsidiary of WuXi AppTec, has secured Pre-Approval Inspection (PAI) for two APIs from the U.S. Food and Drug Administration for its...

WuXi STA Announces to Build a New R&D Center in Shanghai

We are pleased to announce that WuXi's subsidiary, STA Pharmaceutical Co., Ltd, has signed an investment agreement with the government of Shanghai Jinshan District to build a new R&D center. The new...

WuXi AppTec Expands Site in the United States for Drug Development Testing Services

We are pleased to announce the grand opening of WuXi AppTec's expanded Laboratory Testing Division (LTD) facility in New Jersey. The expansion will double total operation space to more than 115,000 square...

FDA UPDATES